Background: The CONVERGE trial demonstrated that hybrid epicardial and endocardial ablation was more effective than catheter ablation for the treatment of persistent atrial fibrillation (AF) at 1 year. Long-term real-world outcome data are scarce.
Objective: We described a single-center experience by evaluating the long-term effectiveness and safety of hybrid epicardial-endocardial ablation.
© LitMetric 2025. All rights reserved.